Incidence and risk factors of late right heart failure in chronic mechanical circulatory support
Artificial Organs · 2023
DOI: 10.1111/aor.14537 ↗At a glance
Journal article in Artificial Organs, 2023. Written by Susanne E A Felix and 8 co-authors. Institution: Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands. Major MEDLINE topics: Heart Failure, Tricuspid Valve Insufficiency, Heart-Assist Devices. Cited 7 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Health~Holland.
Topics: Herzinsuffizienz
Abstract (original language)
Background
Late right heart failure ( LRHF ) is a common complication during long‐term left ventricular assist device ( LVAD ) support. We aimed to identify risk factors for LRHF after LVAD implantation.
Methods
Patients undergoing primary LVAD implantation between 2006 and 2019 and surviving the perioperative period were included for this study ( n = 261). Univariate Cox proportional hazards analysis was used to assess the association of clinical covariates and LRHF , stratified for device type. Variables with p < 0.10 entered the multivariable model. In a subset of patients with complete echocardiography or right catheterization data, this multivariable model was extended. Postoperative cardiopulmonary exercise test data were compared in patients with and without LRHF .
Results
Nineteen percentage of patients suffered from LRHF after a median of 12 months, of which 67% required hospitalization. A history of atrial fibrillation ( AF ) ( HR : 2.06 [1.08–3.93], p = 0.029), a higher preoperative body mass index ( BMI ) ( HR : 1.07 [1.01–1.13], p = 0.023), and intensive care unit ( ICU ) duration ( HR : 1.03 [1.00–1.06], p = 0.025) were independent predictors of LHRF in the multivariable model. A significant relation between the severity of tricuspid regurgitation ( TR ) and LRHF ( HR : 1.91 [1.13–3.21], p = 0.016) was found in patients with echocardiographic data. Patients with LRHF demonstrated a lower maximal workload and peak VO2 at 6 months postoperatively.
Conclusion
A history of AF , BMI, and longer ICU stay may help identify patients at high risk for LRHF . Severity of TR was significantly related to LRHF in a subset of patients
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
- Department of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
- Department of Methodology and Statistics, Utrecht University, Utrecht, The Netherlands.
- Department of Cardiothoracic surgery, Division Heart & Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
- Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
- Health Data Research UK and Institute of Health Informatics, University College London, London, UK.
ORCID profiles: Lieke Numan
Funding
- Health~Holland
Cite
APA
Felix, S. E. A., Numan, L., Oerlemans, M. I. F., Aarts, E., Ramjankhan, F. Z., Gianoli, M., Asselbergs, F. W., De Jonge, N., & Van Laake, L. W. (2023). Incidence and risk factors of late right heart failure in chronic mechanical circulatory support. Artificial Organs. https://doi.org/10.1111/aor.14537
Vancouver
Felix SEA, Numan L, Oerlemans MIF, Aarts E, Ramjankhan FZ, Gianoli M, et al. Incidence and risk factors of late right heart failure in chronic mechanical circulatory support. Artificial Organs. 2023. doi:10.1111/aor.14537
BibTeX
@article{Felix2023,
author = {Felix, Susanne E A and Numan, Lieke and Oerlemans, Marish I F and Aarts, E and Ramjankhan, Faiz Z and Gianoli, Monica and Asselbergs, Folkert W and De Jonge, Nicolaas and Van Laake, Linda W},
title = {Incidence and risk factors of late right heart failure in chronic mechanical circulatory support},
journal = {Artificial Organs},
year = {2023},
doi = {10.1111/aor.14537}
}
EUVIMED